Commentary: When two neighbouring NHS integrated care boards report median elective waits that differ by ten weeks, commentators often blame demographics or luck. The data point to allocation choices that ministers could change but frequently defer.

Latest referral-to-treatment statistics show the national median wait stabilising near 14 weeks, yet boards covering similar age profiles in the Midlands and the North West diverge sharply on orthopaedic and ophthalmology queues. The spread persists even after the elective recovery fund injections of 2022 and 2023, suggesting money alone did not standardise capacity.

Funding follows history, not need

Boards inherit baseline budgets from legacy primary care trust formulas that overweight historic spending rather than current morbidity. Boards that historically underinvested in day-case theatres still lack physical slots, regardless of temporary central grants tagged for “surgical hubs.”

Private outsourcing helped some trusts clear cataract backlogs, but contracts varied in price and governance, creating a postcode lottery in access that mirrors the public queue disparity critics hoped outsourcing would erase.

What would actually equalise waits

Transparency would help: publish board-level theatre utilisation and weekend staffing rather than aggregate national press releases. Harder politically, rebasing allocation toward waiting-list weighted capitation would shift hundreds of millions toward boards with the longest queues—an explicit trade ministers have avoided ahead of tight fiscal years.

Until then, “postcode lottery” is not an accident. It is the predictable output of a funding system that rewards past spend over present need, and calling it luck lets policymakers off the hook.

Political incentives

Ministers prefer announcing national waiting-list totals that show year-on-year improvement, even when internal board tables reveal stagnant tails for hip replacements or varicose vein procedures. Without board-level targets tied to ministerial accountability, the incentive is to celebrate aggregate progress while leaving outliers unaddressed.

Integrated care partnerships promised to merge primary and hospital planning, yet governance meetings still spend disproportionate time on legacy debt and estate maintenance rather than theatre throughput. Digital pre-assessment tools spread unevenly because boards fund them from discretionary transformation pots.

We would support legislation requiring quarterly publication of median waits by procedure and board, with automatic review when gaps exceed eight weeks against the national median. That is less glamorous than a new national hospital brand, but it would force the allocation debate into the open.

Without reform, boards will keep bidding against each other for locum surgeons rather than sharing pooled lists—a politically easy headline but an inefficient use of scarce theatre time.

MPs debating health appropriations this month should ask why board-level median waits are absent from the green book tables ministers cite in the chamber.